These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 27619678)
1. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
3. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633 [TBL] [Abstract][Full Text] [Related]
5. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663 [TBL] [Abstract][Full Text] [Related]
6. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Zhu M; Li M; Wang T; Linghu E; Wu B Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
9. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241 [TBL] [Abstract][Full Text] [Related]
10. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
11. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis. Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097 [TBL] [Abstract][Full Text] [Related]
13. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma. Zhang S; Li J; Wang X Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma. Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma. Hsu HT; Sung MT; Lee CC; Kuo YJ; Chi CW; Lee HC; Hsia CY Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483249 [TBL] [Abstract][Full Text] [Related]
16. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma. Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling. Hu BS; Xiong SM; Li G; Li JP Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549 [TBL] [Abstract][Full Text] [Related]
18. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC. Wang C; Yao B; Xu M; Zheng X Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664 [TBL] [Abstract][Full Text] [Related]
19. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas. Fang T; Cui M; Sun J; Ge C; Zhao F; Zhang L; Tian H; Zhang L; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li H; Li J Oncotarget; 2015 Jun; 6(18):16106-19. PubMed ID: 25965830 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]